HCP5 and prostate carcinoma: Herein, HCP5 was found to be markedly upregulated in malignant OC tumor tissues and OC cell lines, a pattern also observed in lung cancer (Li et al. 2020), prostate cancer (Hu and Lu 2020), and breast cancer (Wang et al. 2019).